Zenas BioPharma, Inc. Common Stock
ZBIO
$26.40-3.15%
End of day · as of Oct 13, 2026, 5:30 AM ET
Mkt cap
$797.99M
EV/Sales
76.6
P/E ratio
N/A
FY2025 Revenue
$10.00M
EPS (TTM)
$-9.63
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-3777.37%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
Latest reported ZBIO revenue for 2025-12-31 was $10.0M. Net income was -$377.7M. Revenue was up 100.0% from 2024-12-31 to 2025-12-31. ZBIO currently screens at market cap $798.0M.
Use this ZBIO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ZBIO income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company in the Healthcare sector.
Latest cached Zenas BioPharma, Inc. Common Stock (ZBIO) revenue for Dec 31, 2025 was $10.0M. Net income was -$377.7M. Statements: https://lician.com/financials/zbio
Zenas BioPharma, Inc. Common Stock (ZBIO) market capitalization is $798.0M on the latest cached snapshot.
Zenas BioPharma, Inc. Common Stock (ZBIO) cached previous close $27.26; day range $26.40 – $26.93; volume 602,492. Session quote: https://lician.com/quote/zbio
The latest cached ZBIO filing is 8-K · Oct 13, 2026. Filings: https://lician.com/sec/zbio